Contract 75D30125D00194
Pfizer Inc · Department Of Health And Human Services · April 3, 2025
Pfizer Inc was awarded a federal contract by Department Of Health And Human Services (Centers For Disease Control And Prevention) on April 3, 2025 for $927.45 million of work in pharmaceutical preparation manufacturing. It was awarded under full and open competition. The contract has been modified 4 times since the base award It uses order dependent (idv allows pricing arrangement to be determined separately for each order) contract pricing. The most recent modification was on June 29, 2026. If all options are exercised, the contract could reach $2.01 billion.
Contract details
- PIID
- 75D30125D00194
- Award type
- Indefinite Delivery / Indefinite Quantity
- Pricing
- Order Dependent (Idv Allows Pricing Arrangement To Be Determined Separately For Each Order)
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- April 3, 2025
- Latest action
- June 29, 2026
Description
END OF PWS
Modification timeline
-
June 29, 2026Mod P00006 · Other Administrative Action$1.12B
-
February 5, 2026Mod P00005 · Funding Only Action$1.12B
-
October 31, 2025Mod P00004 · Funding Only Action$920.93M
-
September 26, 2025Mod P00003 · Funding Only Action$664.51M
-
April 3, 2025Mod P00001$255.08M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Phlow Corp. | Department Of Health And Human Services | July 2, 2026 | $696.67M |
| Sri International | Department Of Health And Human Services | July 2, 2026 | $0 |
| Kymanox Corp | Department Of Health And Human Services | June 25, 2026 | $0 |
| Mckesson Specialty Distribution Llc | Department Of Health And Human Services | June 24, 2026 | $203.93M |
| Mriglobal | Department Of Health And Human Services | June 24, 2026 | $514.9K |
| Eminent Services Corp | Department Of Health And Human Services | June 24, 2026 | $0 |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75D30125D00194?
Contract 75D30125D00194 is a federal contract awarded to Pfizer Inc by Department Of Health And Human Services on April 3, 2025 for $927.45 million of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 4 times since the base award.
Who won contract 75D30125D00194?
Pfizer Inc won contract 75D30125D00194 from Department Of Health And Human Services.
How much is contract 75D30125D00194 worth?
Contract 75D30125D00194 has obligated $927.45 million to date, with a total potential value of $2.01 billion if all options are exercised.